Holen Sie sich die Stockscreener-App
159.89
2.11%
3.30
Handel nachbörslich:
159.88
-0.010
-0.01%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ORCL?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$156.59
Offen:
$160
24-Stunden-Volumen:
39.46M
Relative Volume:
1.42
Marktkapitalisierung:
$459.54B
Einnahmen:
$61.02B
Nettoeinkommen (Verlust:
$15.61B
KGV:
30.05
EPS:
5.3211
Netto-Cashflow:
$-13.18B
1W Leistung:
+3.37%
1M Leistung:
-19.46%
6M Leistung:
-36.06%
1J Leistung:
-10.64%
1-Tages-Spanne:
$156.96
$165.39
1-Wochen-Bereich:
$135.25
$165.39
52-Wochen-Spanne:
$118.86
$345.72
Oracle Corp Stock (ORCL) Company Profile
Firmenname
Oracle Corp
Sektor
Branche
Telefon
(737) 867-1000
Adresse
2300 ORACLE WAY, AUSTIN, CA
Compare ORCL vs MSFT, PLTR, CRWD, SNPS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORCL
Oracle Corp
|
159.89 | 450.05B | 61.02B | 15.61B | -13.18B | 5.3211 |
|
MSFT
Microsoft Corporation
|
413.27 | 3.07T | 305.45B | 119.26B | 77.41B | 15.98 |
|
PLTR
Palantir Technologies Inc
|
139.45 | 340.62B | 4.48B | 1.63B | 2.10B | 0.6363 |
|
CRWD
Crowdstrike Holdings Inc
|
413.61 | 102.87B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
437.45 | 83.97B | 7.05B | 1.34B | 1.35B | 8.0234 |
Oracle Corp Stock (ORCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-04 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-01-12 | Fortgesetzt | Goldman | Buy |
| 2025-12-11 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-12-03 | Eingeleitet | Wells Fargo | Overweight |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-10-09 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-09-25 | Eingeleitet | Rothschild & Co Redburn | Sell |
| 2025-09-10 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-09-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-09-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-09-09 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-07-17 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-07-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-07-02 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-06-30 | Hochstufung | Stifel | Hold → Buy |
| 2025-06-18 | Bestätigt | Guggenheim | Buy |
| 2025-06-13 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-06-09 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-04-23 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-03-19 | Eingeleitet | Stephens | Equal-Weight |
| 2025-03-11 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-03-03 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
| 2025-01-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
| 2024-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-09-16 | Hochstufung | Melius | Hold → Buy |
| 2024-09-10 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-09-10 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-06-17 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-04-18 | Eingeleitet | Oppenheimer | Perform |
| 2024-03-21 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-03-14 | Hochstufung | Argus | Hold → Buy |
| 2024-03-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-03-12 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-12-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2023-11-13 | Hochstufung | Edward Jones | Hold → Buy |
| 2023-10-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-15 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-14 | Hochstufung | DZ Bank | Hold → Buy |
| 2023-09-13 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-09-12 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
| 2023-09-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-08-29 | Hochstufung | UBS | Neutral → Buy |
| 2023-06-13 | Hochstufung | Goldman | Sell → Neutral |
| 2023-06-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-04-20 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2023-03-10 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-01-18 | Eingeleitet | DA Davidson | Neutral |
| 2023-01-11 | Eingeleitet | Mizuho | Buy |
| 2023-01-09 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-05 | Hochstufung | Jefferies | Hold → Buy |
| 2022-10-21 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-20 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2022-09-14 | Eingeleitet | Berenberg | Hold |
| 2022-08-12 | Eingeleitet | Guggenheim | Buy |
| 2022-06-29 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2022-06-27 | Fortgesetzt | Goldman | Sell |
| 2022-06-14 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2022-04-01 | Eingeleitet | Daiwa Securities | Neutral |
| 2022-03-29 | Herabstufung | Exane BNP Paribas | Neutral → Underperform |
| 2022-03-11 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2022-03-11 | Hochstufung | Societe Generale | Hold → Buy |
| 2021-12-21 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-12-15 | Hochstufung | DZ Bank | Sell → Hold |
| 2021-12-10 | Bestätigt | BMO Capital Markets | Market Perform |
| 2021-12-10 | Bestätigt | Barclays | Equal Weight |
| 2021-12-10 | Bestätigt | Citigroup | Neutral |
| 2021-12-10 | Bestätigt | Cowen | Outperform |
| 2021-12-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-12-10 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-12-10 | Bestätigt | Piper Sandler | Neutral |
| 2021-12-10 | Bestätigt | Societe Generale | Hold |
| 2021-12-10 | Bestätigt | Stifel | Hold |
| 2021-12-10 | Bestätigt | UBS | Neutral |
| 2021-12-10 | Bestätigt | Wolfe Research | Peer Perform |
| 2021-11-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-11-02 | Eingeleitet | Deutsche Bank | Hold |
| 2021-09-14 | Bestätigt | BMO Capital Markets | Market Perform |
| 2021-09-14 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-08-10 | Herabstufung | DZ Bank | Hold → Sell |
| 2021-05-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-04-23 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-04-21 | Herabstufung | DZ Bank | Buy → Hold |
| 2021-04-01 | Fortgesetzt | Wedbush | Neutral |
| 2021-03-22 | Fortgesetzt | Evercore ISI | In-line |
| 2021-03-16 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-11 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-03-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2021-03-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-03-03 | Fortgesetzt | Citigroup | Neutral |
| 2021-01-22 | Eingeleitet | Goldman | Sell |
| 2020-12-18 | Hochstufung | Monness Crespi & Hardt | Neutral → Buy |
| 2020-12-16 | Fortgesetzt | BofA Securities | Neutral |
| 2020-12-08 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-11-24 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Fortgesetzt | UBS | Neutral |
| 2020-09-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-09-11 | Bestätigt | BMO Capital Markets | Market Perform |
| 2020-09-11 | Bestätigt | Barclays | Equal Weight |
| 2020-09-11 | Bestätigt | Credit Suisse | Outperform |
| 2020-09-11 | Bestätigt | Goldman | Buy |
| 2020-09-11 | Bestätigt | Jefferies | Hold |
| 2020-09-11 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2020-09-11 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-09-11 | Bestätigt | Stifel | Hold |
| 2020-09-11 | Bestätigt | Wells Fargo | Overweight |
| 2020-06-19 | Herabstufung | Argus | Buy → Hold |
| 2020-06-01 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2020-03-31 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-13 | Bestätigt | BMO Capital Markets | Market Perform |
Alle ansehen
Oracle Corp Aktie (ORCL) Neueste Nachrichten
OHAQ Oracle Healthcare Acquisition Corp. (PNK) 10 Feb 2026: volume spike signals catalyst - Meyka
Investor Outlook: Oracle stock surges after analyst turns bullish - BNN Bloomberg
Clinical Communication and Collaboration Market to Reach US$ 9,430 Million by 2033 as Telemedicine and Cloud-Based Care Accelerate | Astute Analytica - GlobeNewswire Inc.
Is Oracle Stock a Buy Now? - The Globe and Mail
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Oracle, Adobe in focus as BNP Paribas weighs in on enterprise software sell-off (ORCL:NYSE) - Seeking Alpha
Netflix and Oracle among market cap stock movers on Tuesday - Investing.com
The AI Utility Transition: A Comprehensive Research Feature on Oracle Corporation (ORCL) - FinancialContent
Jim Cramer on Oracle (ORCL): “I Don’t Like What They’re Doing to Their Balance Sheet” - Yahoo Finance
Oracle Stock Looks To Extend Rally With OpenAI In Focus - Investor's Business Daily
Bet on These ETFs to Capitalize on Oracle's 10% Hike Post Upgrade - TradingView
Oracle Java licensing worries are percolating through the userbase - theregister.com
Oracle Corporation (ORCL) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Oracle: Strong Generative AI Demand Supports Data Center Buildout - Morningstar Canada
ObvioGo Now Integrated with Oracle Life Sciences Clinical One Data Collection - PR Newswire
Microsoft and Oracle may be bargain stocks, according to this analysis - MarketWatch
Melius downgrades Oracle (ORCL) to hold as AI monetization faces scrutiny - MSN
ORACLE CORPORATION (ORCL) DEADLINE ALERT Bernstein Liebhard LLP Reminds Oracle Corporation Investors of Upcoming Deadline - accessnewswire.com
What's Happening With Oracle Stock? - Forbes
ORCL: Oracle Stock Got Bullish Upgrade - TradingView
What's Going On With Oracle Stock Tuesday? - Benzinga
Oracle AI Agents Help Marketing, Sales, and Service Leaders Enhance Customer Experiences - Oracle
Oracle launches AI agents for supply chain management - StreetInsider
Oracle adds process manufacturing capabilities to cloud platform - StreetInsider
Oracle adds AI agents to cloud applications for marketing, sales, service - StreetInsider
Trending tickers: TSMC, Oracle, AstraZeneca, Kering and Tui - Yahoo Finance UK
Wesbanco Bank Inc. Raises Stake in Oracle Corporation $ORCL - MarketBeat
Winslow Asset Management Inc. Has $31.51 Million Stock Position in Oracle Corporation $ORCL - MarketBeat
Dow Rises as Oracle Advances 9.6%, Tom Lee’s Bitmine Reaches $10 Billion - Eudaimonia and Co
Compagnie Lombard Odier SCmA Has $20.60 Million Stock Holdings in Oracle Corporation $ORCL - MarketBeat
ProShare Advisors LLC Sells 24,617 Shares of Oracle Corporation $ORCL - MarketBeat
CloudAlpha Capital Management Limited Hong Kong Sells 22,900 Shares of Oracle Corporation $ORCL - MarketBeat
SVB Wealth LLC Has $15.42 Million Stock Position in Oracle Corporation $ORCL - MarketBeat
Prospera Financial Services Inc Sells 4,064 Shares of Oracle Corporation $ORCL - MarketBeat
Wealthfront Advisers LLC Purchases 17,997 Shares of Oracle Corporation $ORCL - MarketBeat
Oracle Helps Organizations Enhance Process Manufacturing – Company Announcement - Financial Times
Oracle adds more than 40 agents to Fusion Cloud suite - SiliconANGLE
Oracle Stock (+9.6%): Analyst Upgrade Reframes AI Narrative - Trefis
Kyndryl Holdings, Credo Technology Group, ON Semiconductor, AppLovin Corp And Oracle: Why These 5 Stocks Are On Investors' Radars TodayOracle (NYSE:ORCL) - Benzinga
Why Oracle Stock Popped Today - Yahoo Finance
Oracle Helps Markets Continue Run-Market Analysis for February 9th, 2026 - The Globe and Mail
Stock Movers: Oracle, Kroger, Workday - Bloomberg
Oracle (NYSE:ORCL) Trading 9.9% Higher Following Analyst Upgrade - MarketBeat
Alphabet's debt raise fuels forecasts for record year in corporate bond sales - Reuters
AI-fueled Oracle partner reenergizes buy zone — and big demand - MSN
Oracle Stock Rallies After Analyst Upgrades To Buy, Says Sell-Off 'Overshot' - Investor's Business Daily
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Oracle Heads Toward Key Resistance Levels After Analyst Upgrade. Should You Buy ORCL Stock Here? - Barchart.com
ORCL Investors Have Opportunity to Lead Oracle Corporation Securities Lawsuit - PR Newswire
Oracle Aims for $50B Expansion With Cloud Infrastructure Boost - StocksToTrade
Oracle (ORCL) Stock Trades Up, Here Is Why - Yahoo Finance
Finanzdaten der Oracle Corp-Aktie (ORCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.42%
1.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):